Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases
Clinical trial NCT07413952 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07413952
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2027-12-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.